PD. Dr. Ana Martin-Villalba Department of Molecular ... - HBIGS
PD. Dr. Ana Martin-Villalba Department of Molecular ... - HBIGS
PD. Dr. Ana Martin-Villalba Department of Molecular ... - HBIGS
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>PD</strong>. <strong>Dr</strong>. <strong>Ana</strong> <strong>Martin</strong>-<strong>Villalba</strong><br />
<strong>Department</strong> <strong>of</strong> <strong>Molecular</strong> Neurobiology<br />
German Cancer Research Center<br />
69120 Heidelberg, Germany<br />
Phone: +49-(0)6221-42 3766<br />
Fax: +49-(0)6221-42 3777<br />
E-mail: a.martin-villalba@dkfz.de<br />
13/11/1971, Madrid<br />
CURRICULUM VITAE<br />
July 2006-<br />
March 1999 -<br />
June 2006<br />
Appointed group leader <strong>of</strong> “<strong>Molecular</strong> Neurobiology”<br />
<strong>Department</strong>, German Cancer Research Center, Heidelberg<br />
Group leader at the Division <strong>of</strong> Immunogenetics (Pr<strong>of</strong>. <strong>Dr</strong>.<br />
P.H. Krammer), German Cancer Research Center, Heidelberg<br />
March-Apr.1998 Guest-scientist at the laboratory <strong>of</strong> Pr<strong>of</strong>. R. Testi, University Tor<br />
Jan-Feb.1999 Vergata, Rome, Italy (Vigoni Program)<br />
Jan. 1998 - Postdoctoral fellow, Institute <strong>of</strong> Physiology and Pathophysio-<br />
Feb. 1999 logy, University <strong>of</strong> Heidelberg<br />
June-Dec.1997<br />
Aug. 1995-<br />
July 1998<br />
Medical Assistant at the Neurology <strong>Department</strong>, University <strong>of</strong> Heidelberg<br />
PhD: Institute <strong>of</strong> Physiology and Pathophysiophysiology,<br />
University <strong>of</strong> Heidelberg, Germany<br />
1989 - 1995 Faculty <strong>of</strong> Medicine, University <strong>of</strong> Murcia, Spain<br />
1993 Faculty <strong>of</strong> Medicine, University <strong>of</strong> Leeds, U.K. (ERASMUS-Program)<br />
Summer 1992<br />
University Hospital for Internal Medicine, Vienna, Austria<br />
HONORS<br />
Walther und Christine Richtzenhain-Award (2006)<br />
Heinz Maier-Leibnitz-Award (2006);<br />
Paul Ehrlich und Ludwig Darmstädter Young investigator Award (2006);<br />
German Academic Exchange Service (DAAD), Bonn, Germany (1997)<br />
FIELDS OF INTEREST<br />
<strong>Molecular</strong> Neurobiology, Stem cell biology, Brain tumors, Axonal regeneration, the role <strong>of</strong><br />
CD95/CD95L-system in the CNS
CURRENTLY FUNDED PROJECTS<br />
BMBF, therapy <strong>of</strong> spinal cord injuries; BMBF, therapy <strong>of</strong> Glioblastoma Multiforme; Helmholtz<br />
Allianz on System Biology: Determinants <strong>of</strong> PI(3) kinase signalling as a response to CD95<br />
stimulation. Teilprojekt Nr. BioRN-INb-07: Role <strong>of</strong> CD95 in Inflammatory diseases.<br />
PUBLICATIONS (10 most important publications):<br />
Corsini, N., Sancho-<strong>Martin</strong>ez, I., Laudenklos, S., Glagow, D., Kumar, S., Letellier, E., Koch,<br />
P., Teodorczyk, M., Kleber, S., Klussmann, S., Wiestler, B., Brüstle, O., Gieffers, C., Hill, O.,<br />
Thiemann, M., Seedorf, M., Gretz, N., Sprengel, R., Celikel, T., <strong>Martin</strong>-<strong>Villalba</strong>, A. (-). The<br />
death receptor CD95 activates adult neural stem cells for working memory formation and<br />
brain repair. Cell Stem Cell, In press<br />
Sancho-<strong>Martin</strong>ez I, and <strong>Martin</strong>-<strong>Villalba</strong>,A. (2009). Tyrosine phosphorylation and CD95: a<br />
FAScinating switch. Cell Cycle 8, 838-842.<br />
Kleber S, Sancho-<strong>Martin</strong>ez I, Wiestler B, Beisel A, Gieffers C, Hill O, Thiemann M, Mueller W,<br />
Sykora J, Kuhn A, Schreglmann N, Letellier E, Zuliani C, Klussmann S, Teodorczyk M, Gröne<br />
HJ, Ganten TM, Sültmann H, Tüttenberg J, von Deimling A, Regnier-Vigouroux A, Herold-<br />
Mende C, <strong>Martin</strong>-<strong>Villalba</strong> A. (2008). Yes and PI3K bind CD95 to signal invasion <strong>of</strong><br />
glioblastoma. Cancer Cell, 13:235-248.<br />
Zuliani C, Kleber S, Klussmann S, Wenger T, Kenzelmann M, Schreglmann N, <strong>Martin</strong>ez A,<br />
del Rio JA, Soriano E, Vodrazka P, Kuner R, Groene HJ, Herr I, Krammer PH, <strong>Martin</strong>-<strong>Villalba</strong><br />
A. (2006). Control <strong>of</strong> neuronal branching by the death receptor CD95 (Fas/Apo-1). Cell<br />
Death. Differ. 13:31-40.<br />
Demjen D, Klussmann S, Kleber S, Zuliani C, Stieltjes B, Metzger C, Hirt UA, Walczak H,<br />
Falk W, Essig M, Edler L, Krammer PH, <strong>Martin</strong>-<strong>Villalba</strong> A (2004). Neutralization <strong>of</strong> CD95<br />
ligand promotes regeneration and functional recovery after spinal cord injury. Nature Med.<br />
10:389-395.<br />
Mantamadiotis T, Lemberger T, Bleckmann SC, Kern H, Kretz O, <strong>Martin</strong> <strong>Villalba</strong> A, Tronche<br />
F, Kellendonk C, Gau D, Kapfhammer J, Otto C, Schmid W and Schutz G. (2002) Disruption<br />
<strong>of</strong> CREB function in brain leads to neurodegeneration. Nat Genet, 31, 47-54.<br />
<strong>Martin</strong>-<strong>Villalba</strong> A, Hahne M, Kleber S, Vogel J, Falk W, Schenkel J, Krammer PH (2001).<br />
Therapeutic neutralization <strong>of</strong> CD95-ligand and TNF attenuates brain damage in stroke. Cell<br />
Death Differ. 8:679-686.<br />
<strong>Martin</strong>-<strong>Villalba</strong> A, Herr I, Jeremias I, Hahne M, Brandt R, Vogel J, Schenkel J, Herdegen T,<br />
Debatin K-M (1999). CD-95 –Ligand (Fas-Ligand/APO-1L) and TRAIL mediate ischemiainduced<br />
apoptosis in neurons. J. Neurosci. 19:3809-3817.<br />
Schneider A, Martín-<strong>Villalba</strong> A, Weih F, Vogel J, Wirth T, Schwaninger M (1999). NF-κB is<br />
activated and promotes cell-death following focal cerebral ischemia. Nature Med 5. 554-559.
EXPERIENCE IN THE SUPERVISION OF DOCTORAL CANDIDATES<br />
Member <strong>of</strong> numerous thesis and thesis advisory committees<br />
International reviewer <strong>of</strong> doctoral theses<br />
Supervised 6 doctoral theses<br />
SUPERVISED DISSERTATIONS (last 5 years)<br />
Nina Corsini, PhD (2008) The CD95/CD95L system regulates adult neurogenesis.<br />
Current occupation: Postdoctoral fellow, German Cancer Research Center.<br />
Elisabeth Letellier, PhD (2008). Role <strong>of</strong> CD95/CD95L in the inflammatory response following<br />
spinal cord injury.<br />
Current occupation: Postdoctoral fellow, Luxembourg.<br />
Stefan Klussmann, PhD (2006) Visual and <strong>Molecular</strong> Imaging <strong>of</strong> spinal cord injury<br />
Current occupation: Consultant at McKensey<br />
Deana Demjen, PhD (2006) Neutralization <strong>of</strong> CD95L promotes regeneration following spinal<br />
cord injury.<br />
Current occupation: Project Information and Feasibility Associate at ICON Clinical<br />
Research<br />
Susanne Kleber, PhD (2005) g-Irradiation leads to CD95-dependent invasion <strong>of</strong> glioblastoma<br />
cells.<br />
Current occupation: Postdoctoral fellow, German Cancer Research Center.<br />
Cecilia Zuliani, PhD (2005) The CD95/CD95L system and its role in the developing brain<br />
Current occupation: Postdoctoral fellow, German Cancer Research Center.